{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:20:20Z","timestamp":1767147620230,"version":"build-2238731810"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.maturitas.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T10:46:08Z","timestamp":1398509168000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Menopause-specific quality of life across varying menopausal populations with conjugated estrogens\/bazedoxifene"],"prefix":"10.1016","volume":"78","author":[{"given":"Lucy","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn V.","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Messig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry S.","family":"Komm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Mirkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2014.04.008_bib0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","article-title":"The menopause","volume":"353","author":"Greendale","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0010","first-page":"1","article-title":"Research on the menopause in the 1990. Report of a WHO Scientific Group","volume":"866","year":"1996","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9378(87)90298-5","article-title":"Characteristics of menopausal women seeking assistance","volume":"156","author":"Anderson","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-5122(96)01038-9","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0025","first-page":"465","article-title":"Management of osteoporosis and menopausal symptoms: focus on bazedoxifene\/conjugated estrogen combination","volume":"5","author":"Mirkin","year":"2013","journal-title":"Int J Women's Health"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/GME.0b013e31829f0433","article-title":"Sleep parameters and health-related quality of life with bazedoxifene\/conjugated estrogens: a randomized trial","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":"Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial","volume":"121","author":"Pinkerton","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0065","first-page":"1221","article-title":"Breast parameters with bazedoxifene\/conjugated estrogens in randomized, controlled trials of postmenopausal women","volume":"17","author":"Pinkerton","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13697130903305627","article-title":"Effects of bazedoxifene\/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar\/vaginal atrophy","volume":"13","author":"Bachmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/13697137.2012.717994","article-title":"Effects of bazedoxifene\/conjugated estrogens on endometrial safety and bone in postmenopausal women","volume":"16","author":"Mirkin","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0085","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1210\/jc.2013-1707","article-title":"Effects of bazedoxifene\/conjugated estrogens on the endometrium and bone: a randomized trial","volume":"99","author":"Pinkerton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.maturitas.2004.06.015","article-title":"Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire","volume":"50","author":"Lewis","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0095","article-title":"Confirmatory factor analysis and evaluation of clinically important differences in menopause-specific quality of life associated with bazedoxifene\/conjugated estrogens","author":"Bushmakin","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0100","doi-asserted-by":"crossref","first-page":"A337","DOI":"10.1016\/j.jval.2013.08.091","article-title":"Confirmatory factor analysis and evaluation of clinically important differences in menopause-specific quality of life associated with bazedoxifene\/conjugated estrogens in a vulvar\/vaginal atrophy population","volume":"16","author":"Abraham","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0105","series-title":"Patient-reported outcomes. measurement, implementation and interpretation","author":"Cappelleri","year":"2014"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0110","article-title":"Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy","author":"Savolainen-Peltonen","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0115","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/GME.0b013e318298debe","article-title":"Impact of hormone therapy on quality of life after menopause","volume":"20","author":"Utian","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0120","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life","volume":"348","author":"Hays","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0125","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/archinte.165.17.1976","article-title":"Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial","volume":"165","author":"Brunner","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.287.5.591","article-title":"Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen\/Progestin Replacement Study (HERS) trial","volume":"287","author":"Hlatky","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jwh.2013.4392","article-title":"Evaluation of the efficacy and safety of bazedoxifene\/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) trials","volume":"23","author":"Pinkerton","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0b013e31829f05d1","article-title":"Evaluation of the direct and indirect effects of bazedoxifene\/conjugated estrogens on sleep disturbance using mediation modeling","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2014.04.008_bib0150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/gme.0b013e31803816b8","article-title":"Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ)","volume":"14","author":"Hill","year":"2007","journal-title":"Menopause"}],"updated-by":[{"DOI":"10.1016\/j.maturitas.2014.10.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000}}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T06:39:06Z","timestamp":1668667146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0378512214001273"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.04.008","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopause-specific quality of life across varying menopausal populations with conjugated estrogens\/bazedoxifene","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}